Guidant Galileo
This article was originally published in The Gray Sheet
Executive Summary
CE mark for long coronary blockages makes the intravascular brachytherapy system the only such device approved for treatment of long lesions up to 47 mm and as small as 2.4 mm in Europe, company announces June 5. Longer blockages are at higher risk for developing restenosis following traditional angioplasty or stent implantation, Guidant notes. A PMA for the Galileo is still pending at FDA